Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 3Withdrawn 1Recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

CNS 2Dermatologic 1

Conditions

Neoplasm Metastasis 2Meningioma 2Glioma 2Central Nervous System Vascular Malformations 2Aneurysm 2Carcinoma, Basal Cell 1

Interventions

Cyclophosphamide 1499Cisplatin 1434Paclitaxel 1339Radiotherapy 1310Carboplatin 1266Gemcitabine 1226Docetaxel 1133Bevacizumab 1070Fluorouracil 906Doxorubicin 805Dexamethasone 755Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 697Etoposide 679Irinotecan 639Filgrastim 624Cytarabine 587Nivolumab 586Leucovorin 583Vincristine 517Cetuximab 479Prednisone 478Bortezomib 474Trastuzumab 468Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 444Lenalidomide 436

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Laser Speckle Contrast Imaging × Clear all
NCT01455363 2025-11-24

HPOB

Institut Curie

Phase NA Completed
12 enrolled
Dermatologic

Carcinoma, Basal Cell

NCT05305378 2024-08-07

Intraoperative Laser Speckle Contrast Imaging of Cerebral Blood Flow

Dynamic Light

Completed
8 enrolled
CNS

Aneurysm, Glioma, Meningioma, Neoplasm Metastasis, Central Nervous System Vascular Malformations

NCT05028400 2022-04-12

LSCI-NSURG

Insel Gruppe AG, University Hospital Bern

Phase NA Completed
20 enrolled
CNS

Aneurysm, Glioma, Meningioma, Neoplasm Metastasis, Central Nervous System Vascular Malformations

Data powered by HemOnc (CC BY 4.0) Colophon âš¡